01 September 2003
Calprotectin in the modern diagnosis of Inflammatory Bowel Disease and neoplasms
Adam Szarszewski, Maria Korzon, Anna Liberek, Barbara Kamińska, Maciej ZagierskiMed Sci Monit 2003; 9(4): 60-63 :: ID: 428646
Abstract
Inflammatory Bowel Disease (IBD) and colorectal neoplasms have become recently real diagnostic and therapeutical problems. New research methods are needed, which can help simplify the diagnosis process. Detection of calprotectin in the feaces is expected to become a screening test for IBD and colorectal neoplasms. Calprotectin, a complex calcium binding protein belongs to a major family of proteins produced during the inflammatory process. Calprotectin is produced mainly by neutrophils, but also by monocytes and epithelial cells during inflammatory state, when it can consist up to 60% of cytoplasm. Three groups of patients have been established, in whom level of calprotectin excreted in faeces is significantly higher than in healthy individuals, i.e. patients with IBD, patients with colorectal neoplasms and patients after therapy with non-steroid anti-inflammatory drugs (NSAID). Measurement of calprotectin in feaces can become a valuable diagnostic method in all these conditions thanks to calprotectin stability in feaces and the low cost of the test. In the pediatric population it seems especially important in the children with IBD and, according to many authors, this method has high sensitivity and specificity in this population. It can be useful both in diagnosis of IBD and in monitoring of severity of the process. It seems that the calprotectin test could become a valuable test in patients suspected of IBD or colorectal neoplasm and thus become important addition to colonoscopy, imaging methods and histopathology examinations.
Keywords: calprotectin, ulcerative colitis, Crohn Disease, Colorectal Carcinoma
Editorial
01 April 2024 : Editorial
Editorial: Forty Years of Waiting for Prevention and Cure of HIV Infection – Ongoing Challenges and Hopes for Vaccine Development and Overcoming Antiretroviral Drug ResistanceDOI: 10.12659/MSM.944600
Med Sci Monit 2024; 30:e944600
In Press
21 Mar 2024 : Meta-Analysis
Economic Evaluation of COVID-19 Screening Tests and Surveillance Strategies in Low-Income, Middle-Income, a...Med Sci Monit In Press; DOI: 10.12659/MSM.943863
10 Apr 2024 : Clinical Research
Predicting Acute Cardiovascular Complications in COVID-19: Insights from a Specialized Cardiac Referral Dep...Med Sci Monit In Press; DOI: 10.12659/MSM.942612
06 Mar 2024 : Clinical Research
Enhanced Surgical Outcomes of Popliteal Cyst Excision: A Retrospective Study Comparing Arthroscopic Debride...Med Sci Monit In Press; DOI: 10.12659/MSM.941102
06 Mar 2024 : Clinical Research
Prevalence and Variation of Medical Comorbidities in Oral Surgery Patients: A Retrospective Study at Jazan ...Med Sci Monit In Press; DOI: 10.12659/MSM.943884
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952